Preservation of Immune Repertoire by Selective Depletion of Haploidentical Grafts

Biology of Blood and Marrow Transplantation

Volumn 16, Issue 1, 2010, Pages S68-S74

  Guinan, Eva ^a   Luzmik, Leo ^b   Handgretinger, Rupert ^c   Woolfrey, Ann ^d  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Indexed keywords

ANIMAL; DRUG EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HUMAN; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; METHODOLOGY; NATURAL KILLER CELL; REVIEW; T LYMPHOCYTE; TRANSPLANTATION;

ANIMALS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KILLER CELLS, NATURAL; T-LYMPHOCYTES; TRANSPLANTATION CONDITIONING; TRANSPLANTATION IMMUNOLOGY;

MLCS; MLOWN;

EID: 77953030780     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2009.11.015     Document Type: Article

References (30)

1. Kernan, N.A., Collins, N.H., Juliano, L., Cartagena, T., Dupont, B., O'Reilly, R.J., Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease. Blood 68 (1986), 770–773.
2. Kernan, N.A., Flomenberg, N., Dupont, B., O'Reilly, R.J., Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Identification of host-derived antidonor allocytotoxic T lymphocytes. Transplantation 43 (1987), 842–847.
3. Godder, kt, Hazlett, L.J., Abhyankar, S.H., et al. Partially mismatched related-donor bone marrow transplantation for pediatric patients with acute leukemia: younger donors and absence of peripheral blasts improve outcome. J Clin Oncol(18), 2000, 1856–1866.
4. Aversa, F., Tabilio, A., Velardi, A., et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 339 (1998), 1186–1193.
5. Keever, C.A., Small, T.N., Flomenberg, N., et al. Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts. Blood 73 (1989), 1340–1350.
6. Davies, J.K., Koh, M.B., Lowdell, M.W., Antiviral immunity and T-regulatory cell function are retained after selective alloreactive T-cell depletion in both the HLA-identical and HLA-mismatched settings. Biol Blood Marrow Transplant 10 (2004), 259–268.
7. Amrolia, P.J., Muccioli-Casadei, G., Yvon, E., et al. Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responses. Blood 102 (2003), 2292–2299.
8. Gribben, J.G., Guinan, E.C., Boussiotis, V.A., et al. Complete blockade of B7 mediated costimulation is necessary to induce human alloantigen specific anergy: a method to ameliorate graft versus host disease and extend the donor pool. Blood 87 (1996), 4887–4893.
9. Schwartz, R.H., Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71 (1992), 1065–1068.
10. Tan, P., Anasetti, C., Hansen, J.A., et al. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J Exp Med 177 (1993), 165–173.
11. Gimmi, C.D., Freeman, G.J., Gribben, J.G., et al. B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc Natl Acad Sci USA 88 (1991), 6575–6579.
12. Boussiotis, V.A., Barber, D.L., Lee, B.J., Gribben, J.G., Freeman, G.J., Nadler, L.M., Differential association of protein tyrosine kinases with the T cell receptor is linked to the induction of anergy and its prevention by B7 family mediated costimulation. J Exp Med 184 (1996), 365–376.
13. Davies, J.K., Gribben, J.G., Brennan, L.L., Yuk, D., Nadler, L.M., Guinan, E.C., Outcome of alloanergized haploidentical bone marrow transplantation after ex vivo costimulatory blockade: results of 2 phase 1 studies. Blood 112 (2008), 2232–2241.
14. Guinan, E.C., Boussiotis, V.A., Neuberg, D., et al. Transplantation of anergic histoincompatible bone marrow allografts. N Engl J Med 340 (1999), 1704–1714.
15. Taylor, P.A., Friedman, T.M., Korngold, R., Noelle, R.J., Blazar, B.R., Tolerance induction of alloreactive T cells via ex vivo blockade of the CD40:CD40L costimulatory pathway results in the generation of a potent immune regulatory cell. Blood 99 (2002), 4601–4609.
16. Berenbaum, M.C., Brown, I.N., Prolongation of homograft survival in mice with single doses of cyclophosphamide. Nature, 200, 1963, 84.
17. Mayumi, H., Himeno, K., Tokuda, N., Nomoto, K., Drug-induced tolerance to allografts in mice. VII. Optimal protocol and mechanism of cyclophosphamide-induced tolerance in an H-2 haplotype-identical strain combination. Transplant Proc 18 (1986), 363–369.
18. Strauss, G., Osen, W., Debatin, K.M., Induction of apoptosis and modulation of activation and effector function in T cells by immunosuppressive drugs. Clin Exp Immunol 128 (2002), 255–266.
19. Luznik, L., Jalla, S., Engstrom, L.W., Iannone, R., Fuchs, E.J., Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide. Blood 98 (2001), 3456–3464.
20. Santos, G.W., Tutschka, P.J., Brookmeyer, R., et al. Cyclosporine plus methylprednisolone versus cyclophosphamide plus methylprednisolone as prophylaxis for graft-versus-host disease: a randomized, double-blind study in patients undergoing allogeneic marrow transplantation. Clin Transplant 1 (1987), 21–28.
21. Luznik, L., Engstrom, L.W., Iannone, R., Fuchs, E.J., Posttransplantation cyclophosphamide facilitates engraftment of major histocompatibility complex-identical allogeneic marrow in mice conditioned with low-dose total body irradiation. Biol Blood Marrow Transplant 8 (2002), 131–138.
22. Luznik, L., O'Donnell, P.V., Symons, H.J., et al. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant 14 (2008), 641–650.
23. O'Donnell, P.V., Luznik, L., Jones, R.J., et al. Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide. Biol Blood Marrow Transplant 8 (2002), 377–386.
24. Brodsky, R.A., Luznik, L., Bolanos-Meade, J., Leffell, M.S., Jones, R.J., Fuchs, E.J., Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases. Bone Marrow Transplant 42 (2008), 523–527.
25. Handgretinger, R., Klingebiel, T., Lang, P., et al. Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children. Bone Marrow Transplant 27 (2001), 777–783.
26. Ruggeri, L., Capanni, M., Urbani, E., et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295 (2002), 2097–2100.
27. Schumm, M., Feuchtinger, T., Pfeiffer, M., et al. Flow cytometry with anti HLA-antibodies: a simple but highly sensitive method for monitoring chimerism and minimal residual disease after HLA-mismatched stem cell transplantation. Bone Marrow Transplant 39 (2007), 767–773.
28. Chaleff, S., Otto, M., Barfield, R.C., et al. A large-scale method for the selective depletion of alphabeta T lymphocytes from PBSC for allogeneic transplantation. Cytotherapy 9 (2007), 746–754.
29. Meeh, P.F., King, M., O'Brien, R.L., et al. Characterization of the gammadelta T cell response to acute leukemia. Cancer Immunol Immunother 55 (2006), 1072–1080.
30. Godder, K.T., Henslee-Downey, P.J., Mehta, J., et al. Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation. Bone Marrow Transplant 39 (2007), 751–757.